U.S. Supreme Court to take up nursing home arbitration case

The validity of arbitration clauses in nursing home residency agreements will be decided by the U.S. Supreme Court, as justices have agreed to hear a case against two Kentucky facilities.

According to the Courthouse News Service, Extendicare and Kindred Nursing Centers, the parent companies of the nursing homes being sued, had patients’ legal representatives sign agreements that specified claims against the nursing home would be decided by arbitration, not in the courts. The companies tried to exercise this clause when sued by several patients' families for personal injuries and wrongful death, but several courts, including the Kentucky Supreme Court, ruled against them. 

“The authority to enter into a pre-dispute arbitration agreement was not among the powers granted to respective attorney-in-fact and, therefore the arbitration agreements were not formed with the assent of the party to be bound thereby,” the Court’s ruling said. "Lacking the essential element of assent, we conclude that the arbitration agreements in those cases were never validly formed.”

It could be one of several court battles brewing over mandatory arbitration agreements in nursing homes. After CMS finalized a new long-term care rule banning those clauses in future agreements, nursing homes’ top trade group filed a lawsuit seeking to block that provision from going into effect on Nov. 28.

For more on the Kentucky case and the legal argument from nursing homes, click on the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Trimed Popup
Trimed Popup